Effects of desflurane on spinal somatosensory-evoked potentials and conductive spinal cord evoked potential

Spine (Phila Pa 1976). 2003 Aug 15;28(16):1845-50. doi: 10.1097/01.BRS.0000083459.54468.88.

Abstract

Study design: Spinal somatosensory-evoked potential (interspinous-space-recorded evoked potentials after peripheral nerve or dermatomal stimulation) and conductive spinal cord evoked potential (interspinous-space-recorded evoked potentials after spinal cord stimulation) were analyzed in rats under different concentrations of the anesthetic desflurane.

Objectives: To investigate and compare the effects of a new volatile anesthetic, desflurane, on the common intraoperative neuromonitoring models.

Summary of background data: Intraoperative evoked potentials are sensitive to most anesthetics. Interpretation of the data becomes complicated because of a suppression effect caused by the anesthesia. Desflurane has become a valuable anesthetic in neurosurgery because of its pharmacokinetic advantages.

Methods: Fifteen rats were placed under general anesthesia, and vital signs were closely monitored. Needle recording electrodes were placed stereotactically into the thoracolumbar interspinous ligament; dermatomal somatosensory-evoked potential by L5 dermatome, mixed-nerve somatosensory-evoked potential by sciatic nerve stimulation, and spinal cord evoked potential of the same recording electrodes elicited by C2-C3 interspinous stimulation were obtained. The effects of desflurane were examined at end-tidal concentrations of 6% (1.05 minimal alveolar concentration), 9% (1.57 minimal alveolar concentration), and 12% (2.10 minimal alveolar concentration).

Results: Amplitude decreased and latency was delayed in all three kinds of potentials, and the more so with higher concentrations. Comparing 9% with 6% desflurane, the amplitude in dermatomal somatosensory-evoked potential, mixed-nerve somatosensory-evoked potential, and spinal cord evoked potential decreased to 84.3%, 88.9%, and 70.8%, respectively, values with no statistically significant difference. However, at 12%, again compared with 6%, the amplitude decreased further to 64.4%, 70.3%, 41.8%, respectively; mixed-nerve somatosensory-evoked potential and dermatomal somatosensory-evoked potential were significantly more preserved than spinal cord evoked potential (P = 0.04).

Conclusions: The concentration of desflurane alters the amplitude of somatosensory-evoked potential and spinal cord evoked potential, and, to a lesser degree, delays the latency; spinal cord evoked potential is more liable to be suppressed than somatosensory-evoked potential. The dose-dependent suppression effect on amplitude should be considered when interpreting changes during surgery. Furthermore, the potential benefit of somatosensory-evoked potential elicited by direct major nerve stimulation should be considered because of its large amplitude and higher resistance, even with a greater concentration of volatile anesthetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Animals
  • Blood Pressure / drug effects
  • Desflurane
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Evoked Potentials / drug effects*
  • Evoked Potentials, Somatosensory / drug effects*
  • Isoflurane / analogs & derivatives*
  • Isoflurane / pharmacology*
  • Rats
  • Rats, Wistar
  • Spinal Cord / drug effects*
  • Spinal Cord / physiology

Substances

  • Anesthetics, Inhalation
  • Desflurane
  • Isoflurane